Embolized ischemic lesions of toes in an afibrinogenemic patient: possible relevance to in vivo circulating thrombin

Thrombin Binds to Soluble Fibrin Degradation Products Where it Is Protected From Inhibition by Heparin-Antithrombin but Susceptible to Inactivation by Antithrombin-Independent Inhibitors

Jeffrey I. Weitz, Beverly A. Leslie, Monika Hudoba · Circulation · 1998 · 195 citations · Full text

Medicine, Pharmacology, Clinical Biochemistry +13

von Willebrand factor interaction with the glycoprotein IIb/IIa complex. Its role in platelet function as demonstrated in patients with congenital afibrinogenemia.

L. De Marco, Antonio Girolami, T S Zimmerman et al. · Journal of Clinical Investigation · 1986 · 172 citations · Full text

Medicine, Hematology, Physiology +17

Identification and Characterization of the Thrombin Binding Sites on Fibrin

David A. Meh, Kevin R. Siebenlist, Michael W. Mosesson · Journal of Biological Chemistry · 1996 · 137 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +15

Evaluation of the inhibition by heparin and hirudin of coagulation activation during r-tPA-induced thrombolysis

Massoud Mirshahi, J. Soria, C. Soria et al. · Blood · 1989 · 117 citations · Full text

Medicine, Biochemistry, Pharmacology +12

A new type of congenital dysfibrinogenaemia with defective fibrin lysis—Dusard syndrome: possible relation to thrombosis

J Soria, Claudine Soria, Jacques Caen · British Journal of Haematology · 1983 · 82 citations

Medicine, Hematology, Pathology +17